Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.

Moody MA, Liao HX, Alam SM, Scearce RM, Plonk MK, Kozink DM, Drinker MS, Zhang R, Xia SM, Sutherland LL, Tomaras GD, Giles IP, Kappes JC, Ochsenbauer-Jambor C, Edmonds TG, Soares M, Barbero G, Forthal DN, Landucci G, Chang C, King SW, Kavlie A, Denny TN, Hwang KK, Chen PP, Thorpe PE, Montefiori DC, Haynes BF.

J Exp Med. 2010 Apr 12;207(4):763-76. doi: 10.1084/jem.20091281. Epub 2010 Apr 5.

2.

Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection.

Cella M, Presti R, Vermi W, Lavender K, Turnbull E, Ochsenbauer-Jambor C, Kappes JC, Ferrari G, Kessels L, Williams I; CHAVI Clinical Core B, McMichael AJ, Haynes BF, Borrow P, Colonna M; NIAID Center for HIV/AIDS Vaccine Immunology.

Eur J Immunol. 2010 Apr;40(4):949-54. doi: 10.1002/eji.200940234.

3.

Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.

Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR.

AIDS. 2009 Oct 23;23(16):2069-77. doi: 10.1097/QAD.0b013e32832faea5.

PMID:
19710597
4.

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM.

J Exp Med. 2009 Jun 8;206(6):1273-89. doi: 10.1084/jem.20090378. Epub 2009 Jun 1.

5.

T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication.

Ochsenbauer-Jambor C, Jones J, Heil M, Zammit KP, Kutsch O.

Biotechniques. 2006 Jan;40(1):91-100.

6.

Intestinal macrophages: unique effector cells of the innate immune system.

Smith PD, Ochsenbauer-Jambor C, Smythies LE.

Immunol Rev. 2005 Aug;206:149-59. Review.

PMID:
16048547
7.

WNT1 and WNT3a promote expansion of melanocytes through distinct modes of action.

Dunn KJ, Brady M, Ochsenbauer-Jambor C, Snyder S, Incao A, Pavan WJ.

Pigment Cell Res. 2005 Jun;18(3):167-80.

PMID:
15892713
8.

Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.

Ochsenbauer-Jambor C, Delos SE, Accavitti MA, White JM, Hunter E.

J Virol. 2002 Aug;76(15):7518-27.

9.

Palmitoylation of the Rous sarcoma virus transmembrane glycoprotein is required for protein stability and virus infectivity.

Ochsenbauer-Jambor C, Miller DC, Roberts CR, Rhee SS, Hunter E.

J Virol. 2001 Dec;75(23):11544-54.

Supplemental Content

Loading ...
Support Center